| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/15/2010 | US7737260 a protein conjugate comprising a physiologically active polypeptide, a non-peptide polymer and an immunoglobulin Fc fragment, with improved in vivo duration and stability; nonimmunogenic |
| 06/15/2010 | US7737254 Chimeric human T1R1 taste receptor polypeptides and compositions containing same |
| 06/15/2010 | US7737116 Modified and stabilized GDF propeptides and uses thereof |
| 06/15/2010 | US7737111 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases |
| 06/15/2010 | US7736873 An isolated nucleic acid molecule comprising a nucleotide sequence which encodes the polypeptide comprising the outer membrane protein antigens of gramnegative bacteria, which can be used to prevent and treat gramnegative bacteria infection in mammals, such as humans; immunology; vaccines |
| 06/15/2010 | US7736862 screening for high affinity agonists, antagonists and inverse agonists of taste activity; Such compounds could be useful as additives in foods, beverages and drugs |
| 06/15/2010 | US7736653 Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier |
| 06/10/2010 | WO2010065969A1 Sparc binding scfcs |
| 06/10/2010 | WO2010065962A2 Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease |
| 06/10/2010 | WO2010065815A2 Mini-hepcidin peptides and methods of using thereof |
| 06/10/2010 | WO2010065174A1 Novel semi-synthetic glycopeptides as antibacterial agents |
| 06/10/2010 | WO2010064838A2 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient |
| 06/10/2010 | WO2010064748A1 Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins |
| 06/10/2010 | WO2010064734A1 Immobilization substrate and method for producing the same |
| 06/10/2010 | WO2010063172A1 An elp fusion protein and uses thereof |
| 06/10/2010 | WO2010063124A1 Peptide therapeutic conjugates and uses thereof |
| 06/10/2010 | WO2010063123A1 Leptin and leptin analog conjugates and uses thereof |
| 06/10/2010 | WO2010063122A1 Conjugates of neurotensin or neurotensin analogs and uses thereof |
| 06/10/2010 | US20100145024 Long wavelength engineered fluorescent proteins |
| 06/10/2010 | US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
| 06/10/2010 | US20100143973 Interleukin-11 Fusion Proteins |
| 06/10/2010 | US20100143410 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 06/10/2010 | US20100143374 Diagnostic and therapeutic target for autoimmune diseases and uses thereof |
| 06/10/2010 | DE4419264B4 Antigen, um Menschen und Tieren eine schützende Immunität gegen Wurminfektionen zu verleihen To confer antigen humans and animals protective immunity against worm infections |
| 06/10/2010 | CA2745923A1 Sparc binding scfvs |
| 06/10/2010 | CA2745603A1 Use of phenol soluble modulins for the development of vaccines |
| 06/10/2010 | CA2745527A1 Leptin and leptin analog conjugates and uses thereof |
| 06/10/2010 | CA2745524A1 Conjugates of neurotensin or neurotensin analogs and uses thereof |
| 06/10/2010 | CA2745499A1 Peptide therapeutic conjugates and uses thereof |
| 06/10/2010 | CA2745446A1 Novel semi-synthetic glycopeptides as antibacterial agents |
| 06/09/2010 | EP2194065A1 Crystal structure of cd147 extracellular region and use thereof |
| 06/09/2010 | EP1385864B1 Anti-VEGF-2 antibodies |
| 06/09/2010 | EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis |
| 06/09/2010 | CN1798770B Peptabody for cancer treatment |
| 06/09/2010 | CN1630863B Method for crystallizing human GSK3 and novel crystal structure thereof |
| 06/09/2010 | CN1517437B Vaccine for specificity treating tumour or endocellular infection and application |
| 06/09/2010 | CN101724027A Protein trimerization module and application thereof |
| 06/09/2010 | CN101721686A Interferon-thymosin broad-spectrum antiviral pharmaceutical preparation for pigs and preparation method thereof |
| 06/08/2010 | US7732377 Methods for producing members of specific binding pairs |
| 06/03/2010 | WO2010062966A2 Methods for inducing mixed chimerism |
| 06/03/2010 | WO2010062697A2 Membrane-integrated viral dna-packaging motor protein connector biosensor for dna sequencing and other uses |
| 06/03/2010 | WO2010033854A3 Avian derived fusion proteins |
| 06/03/2010 | US20100136660 Methods for producing members of specific binding pairs |
| 06/03/2010 | US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/03/2010 | US20100136625 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |
| 06/03/2010 | US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/03/2010 | US20100136017 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 06/03/2010 | US20100135957 Chimeric Heteromultimer Adhesins |
| 06/03/2010 | CA2741373A1 Membrane-integrated viral dna-packaging motor protein connector biosensor for dna sequencing and other uses |
| 06/02/2010 | EP2192131A1 Immunoglobulins devoid of light chains |
| 06/02/2010 | EP2192128A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/02/2010 | EP2190880A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 06/02/2010 | EP1534736B1 Nogo receptor antagonists |
| 06/02/2010 | CN1800385B Hybrid expression of neisserial proteins |
| 06/02/2010 | CN1659180B Novel recombinant anticoagulant proteins |
| 06/02/2010 | CN1354755B Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/02/2010 | CN101717779A Fusion protein suitable for anthrax antitoxin and vaccines |
| 06/02/2010 | CN101717450A Antibiotic peptide LFB-ME and preparation method thereof |
| 06/02/2010 | CN101717449A Recombinant TRAIL-Fc fusion protein as well as preparation and application thereof |
| 06/02/2010 | CN101143902B Anti-HER2 single-chain antibody-cefuroxime sodium enhanced fusion protein HER2(Fv-LDM) |
| 06/01/2010 | US7728121 Nucleotide sequences coding portion of viral early gene; generating immunoglobulin for detecting viral infection |
| 06/01/2010 | CA2442679C Methods for secretory production of proteins |
| 06/01/2010 | CA2353816C Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation |
| 06/01/2010 | CA2221495C Methods and uses for apoptin |
| 06/01/2010 | CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 06/01/2010 | CA2160800C Ctp modified gonadotropic proteins |
| 06/01/2010 | CA2115839C Hla-restricted hepatitis b virus ctl epitopes |
| 05/27/2010 | WO2010058707A1 Fusion collagenase to which affinity tag is attached, and method for producing same |
| 05/27/2010 | WO2010057501A1 Priming of an immune response |
| 05/27/2010 | WO2010057259A1 Protein stability assay using a fluorescent reporter of protein folding |
| 05/27/2010 | WO2010011096A3 A polypeptide complex comprising non-peptidyl polymer having three functional ends |
| 05/27/2010 | WO2009154804A3 Twin fluorophore peptide nucleic acid hybridization probes |
| 05/27/2010 | US20100130728 Taci-immunoglobulin fusion proteins |
| 05/27/2010 | US20100129384 Taci-immunoglobulin fusion proteins |
| 05/27/2010 | CA2781197A1 Hiv/siv vaccines for the generation of mucosal and systemic immunity |
| 05/27/2010 | CA2744286A1 Fusion collagenase in which affinity tag is linked and method for producing the same |
| 05/27/2010 | CA2743229A1 Priming of an immune response |
| 05/26/2010 | EP2189528A1 Fluorescent protein with deep blue color |
| 05/26/2010 | EP2189476A1 Novel polypeptide and production method thereof |
| 05/26/2010 | EP2189475A2 Fibroblast growth factor-like polypeptides |
| 05/26/2010 | EP1660650B1 Improved sso7-polymerase conjugate proteins |
| 05/26/2010 | EP1448602B1 Modified anti-tnf alpha antibody |
| 05/26/2010 | EP1144642B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 05/26/2010 | CN1726228B Monitor protein for measuring processing of protein |
| 05/26/2010 | CN1723219B Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 05/26/2010 | CN1665934B GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/26/2010 | CN1425066B Novel stra6 polypeptides |
| 05/26/2010 | CN101712964A Fusion protein for inhibiting formation of osteoclast and preparation method as well as pharmaceutical composition thereof |
| 05/26/2010 | CN101712722A Glp-1 fusion proteins |
| 05/26/2010 | CN101712721A T cell receptor fusions and conjugates and methods of use thereof |
| 05/26/2010 | CN101712720A Human antibodies that bind human TNF alpha |
| 05/26/2010 | CN101711865A vaccine compositions containing amyloid beta1-6 antigen arrays |
| 05/26/2010 | CN101100672B Modified HPV E6-E7 fusion gene and coding protein thereof |
| 05/25/2010 | US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins |
| 05/25/2010 | US7723490 Process for correction of a disulfide misfold in Fc molecules |
| 05/25/2010 | US7723482 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 05/25/2010 | US7723481 G protein coupled receptor (GPCR) polypeptide, attached to a detectable label seleacted from green fluorescent polypeptide or a rhodopsin polypeptide, involved in bitter taste transduction; used as additives for foods, beverages and drugs in order to modify T2R-associated bitter taste |
| 05/25/2010 | US7723479 BSL3 polypeptides |
| 05/25/2010 | US7723270 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 05/25/2010 | US7723051 HT2R75 taste receptor and related assays for identifying human bitter taste modulators |